Skip to content

Embecta Corp. EMBC Earnings yield

Earnings yield at other companies

Insulet logo
InsuletPODD
2%-0.1pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-7.2%-2.4pp
Medtronic logo
MedtronicMDT
4.6%+0.3pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-14.9%
Mannkind logo
MannkindMNKD
1.8%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
-14.9%

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on trailing twelve months.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s earnings yield?
Embecta Corp. (EMBC) reported earnings yield of 21.4% in Q1 2026.
How has Embecta Corp.'s earnings yield changed year-over-year?
Embecta Corp.'s earnings yield increased by 200.1% year-over-year, from 7.1% to 21.4%.
What is the long-term trend for Embecta Corp.'s earnings yield?
Over 3 years (2022 to 2025), Embecta Corp.'s earnings yield has grown at a -7.5% compound annual growth rate (CAGR), from 14.6% to 11.6%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.